) was a big mover last session with shares rising nearly 17% on the
day. The move came on solid volume too with far more shares
changing hands than in a normal session. This continues the recent
uptrend for the company, as the stock is now up over 24% in the
past one-month time frame.
This drug manufacturer has seen one positive estimate revision in
the last 30 days, and the Zacks Consensus Estimate has also moved
higher over the same time frame. This implies more solid trading
ahead for the company. So make sure to keep an eye on this stock
going forward to see if yesterday's sharp climb can turn into more
strength down the road.
Zogenix currently holds a Zacks Rank #2 (Buy) while its
Other Med-Drug stocks worth considering include
Sucampo Pharmaceuticals, Inc.
Jazz Pharmaceuticals Public Limited Company
Questcor Pharmaceuticals, Inc.
). While Sucampo sports a Zacks Rank #1 (Strong Buy), Jazz
Pharmaceuticals and Questcor carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
JAZZ PHARMACEUT (JAZZ): Free Stock Analysis
QUESTCOR PHARMA (QCOR): Free Stock Analysis
SUCAMPO PHARMAC (SCMP): Free Stock Analysis
ZOGENIX INC (ZGNX): Free Stock Analysis Report
To read this article on Zacks.com click here.